Related Experiment Video

Updated: Jul 3, 2026

Basophil Activation Test for Allergy Diagnosis
07:22

Basophil Activation Test for Allergy Diagnosis

Published on: May 31, 2021

An update on childhood urticaria and angioedema

Evan Bailey1, Marcus Shaker

  • 1Loyola University Stritch School of Medicine, Chicago, Illinois, USA.

Current Opinion in Pediatrics
|July 16, 2008
PubMed

Insights

Urticaria, a common skin condition, presents in acute and chronic forms with diverse triggers. Understanding specific subtypes and their unique treatments, including novel therapies, is crucial for effective pediatric patient management.

Area of Science:

  • Pediatric Dermatology
  • Allergology and Immunology
  • Clinical Medicine

Background:

  • Urticaria, encompassing acute and chronic forms, is a prevalent condition in children.
  • Identifying diverse triggers and subtypes is essential for effective management.
  • The pathophysiology, diagnosis, and treatment of urticarial syndromes require ongoing updates.

Purpose of the Study:

  • To review acute and chronic urticaria in pediatric populations.
  • To discuss the differential diagnosis of urticarial syndromes.
  • To provide updates on urticaria pathophysiology, diagnosis, and treatment.

Main Methods:

  • Literature review of recent publications on pediatric urticaria.
  • Analysis of diagnostic criteria and therapeutic approaches.
  • Synthesis of information on urticaria subtypes and triggers.

Main Results:

  • Urticaria subtypes show differential responses to therapies.
  • Allergic and infectious triggers necessitate thorough patient evaluation.
  • Distinguishing idiopathic urticaria from anaphylaxis, systemic conditions, and autoimmune urticaria is critical.

Conclusions:

  • Urticaria is common, with increasing understanding of specific subtypes.
  • Individualized patient assessment is vital to identify triggers and exclude other etiologies.
  • Targeted therapies, including novel options like omalizumab, are advancing urticaria treatment.
Abstract

Related Concept Videos

Allergic Reactions: Anaphylaxis01:30

Allergic Reactions: Anaphylaxis

Anaphylaxis is a severe, life-threatening hypersensitivity reaction mediated by Immunoglobulin E (IgE) antibodies. When IgE binds to allergens, it triggers the release of mediators– histamine, leukotrienes, and prostaglandins from mast cells and basophils. These mediators cause vasodilation, edema, and inflammation, leading to various symptoms.The primary allergens causing anaphylaxis include food items (e.g., peanuts, shellfish), drugs (e.g., penicillin, asparaginase, corticotropin, heparin),...
Allergic Reactions02:06

Allergic Reactions

Overview
Hypersensitivities01:30

Hypersensitivities

Hypersensitivity, also known as a hypersensitivity reaction or allergic reaction, is a condition where the body's immune system reacts abnormally to a foreign substance. Such substances, that cause hypersensitivity are referred to as an allergen, could be something typically harmless to most people, like pollen or certain foods.
Types of Hypersensitivities
Hypersensitivity reactions are categorized into four types: Type 1, Type 2, Type 3, and Type 4. Each type has a distinct mechanism...
Allergic Drug Reactions01:27

Allergic Drug Reactions

Allergic reactions related to drugs are hypersensitivity responses driven by the immune system and bear no connection to the drug's therapeutic action. While drugs in isolation do not trigger an immune response, they can interact with endogenous proteins to form antigens. These antigens stimulate lymphocytes to produce antibodies. IgE-type antibodies attach themselves to mast cells. Upon subsequent exposure to the same stimulus, the antigen-antibody interaction is initiated, unleashing numerous...
Antiasthma Drugs: Mast Cell Stabilizers and Anti-IgE Drugs01:25

Antiasthma Drugs: Mast Cell Stabilizers and Anti-IgE Drugs

Asthma is a chronic respiratory condition for which new therapeutic avenues, including anti-inflammatory drugs like mast cell stabilizers and anti-IgE treatments, continue to be developed.
Mast cell stabilizers, such as cromolyn (also known as sodium cromoglycate) and nedocromil (Tilade), are effective drugs in asthma management. These stabilizers hinder histamine release by skillfully obstructing the activation of mast cells and other cellular entities. Notably, they navigate this task without...
Hypersensitivity Reactions: Delayed Hypersensitivity Reactions01:29

Hypersensitivity Reactions: Delayed Hypersensitivity Reactions

Delayed-Type Hypersensitivity (DTH), or Type IV hypersensitivity, is a cell-mediated immune response. It occurs when T cells, rather than antibodies, mediate a reaction to specific antigens. It is characterized by a delayed onset (1-2 days) and involves the recruitment of macrophages to the inflammation site.The initiation of a DTH response begins with the sensitization of T cells. During this phase, which lasts at least 1-2 weeks, antigen-specific T cells are activated, clonally expanded, and...